- JP-listed companies
- PhoenixBio Co.,Ltd.
- Balance sheet
PhoenixBio Co.,Ltd. (6190) Balance sheet
Market cap
¥1.5B
P/E ratio
19.6x
Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Cash and cash equivalents | - | 668 | 1,604 | 1,635 | 933 | 657 | 1,775 | 1,328 | 1,326 | 1,555 | 1,385 | 1,149 | 1,147 |
| Marketable securities, current | - | - | - | - | - | - | - | - | - | - | 0 | 1 | 1 |
| Total current assets | - | 926 | 1,888 | 1,927 | 1,343 | 1,135 | 2,257 | 1,799 | 1,854 | 2,292 | 2,132 | 1,717 | 1,643 |
| Property, plant and equipment, net | - | 435 | 438 | 447 | 450 | 470 | 508 | 702 | 410 | 539 | 543 | 528 | 518 |
| Marketable securities, non-current | - | - | - | - | - | - | - | - | - | 125 | 9 | 9 | 10 |
| Total non-current assets | - | 445 | 450 | 459 | 826 | 770 | 527 | 717 | 426 | 727 | 583 | 568 | 549 |
| Total assets | - | 1,370 | 2,337 | 2,385 | 2,169 | 1,905 | 2,784 | 2,516 | 2,280 | 3,019 | 2,715 | 2,285 | 2,193 |
| Short-term debt | - | - | - | - | - | - | 200 | - | - | - | 100 | 100 | 110 |
| Long-term debt, current | - | 53 | 53 | 56 | 56 | 26 | 20 | 2 | - | - | 80 | 80 | 80 |
| Total current liabilities | - | 135 | 219 | 142 | 221 | 304 | 535 | 399 | 439 | 1,286 | 421 | 567 | 373 |
| Total non-current liabilities | - | 179 | 143 | 140 | 91 | 58 | 1,088 | 1,024 | 1,014 | 218 | 496 | 353 | 267 |
| Total liabilities | - | 313 | 362 | 282 | 312 | 363 | 1,622 | 1,422 | 1,452 | 1,504 | 918 | 920 | 640 |
| Retained earnings | - | -828 | -703 | -574 | -845 | -1,143 | -1,558 | -1,796 | -2,104 | -1,610 | -1,584 | -2,033 | -1,908 |
| Stockholders' equity | 900 | 1,057 | 1,975 | 2,104 | 1,857 | 1,543 | 1,162 | 1,094 | 828 | 1,514 | 1,798 | 1,365 | 1,552 |